These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25431064)

  • 1. High-throughput cell death assays.
    Pamenter ME; Haddad GG
    Methods Mol Biol; 2015; 1254():153-63. PubMed ID: 25431064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput approaches to measuring cell death.
    Saunders DN; Falkenberg KJ; Simpson KJ
    Cold Spring Harb Protoc; 2014 Jun; 2014(6):591-601. PubMed ID: 24890217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput, multiplex cell death assay using an RNAi screening approach.
    Falkenberg KJ; Saunders DN; Simpson KJ
    Cold Spring Harb Protoc; 2014 Jun; 2014(6):663-76. PubMed ID: 24890208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Cell Toxicity Assays.
    Murray D; McWilliams L; Wigglesworth M
    Methods Mol Biol; 2016; 1439():245-62. PubMed ID: 27317000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis-driven screening.
    Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
    Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplexing high-content flow (HCF) and quantitative high-throughput screening (qHTS) to identify compounds capable of decreasing cell viability, activating caspase 3/7, expressing annexin V, and changing mitochondrial membrane integrity.
    Mathews LA; Keller JM; McKnight C; Michael S; Shinn P; Liu D; Staudt LM; Thomas CJ; Ferrer M
    Curr Protoc Chem Biol; 2013; 5(3):195-212. PubMed ID: 24391083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of ambient mass spectrometry in high-throughput screening.
    Li LP; Feng BS; Yang JW; Chang CL; Bai Y; Liu HW
    Analyst; 2013 Jun; 138(11):3097-103. PubMed ID: 23549078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of high-throughput screening assays for poly(ADP-ribose) polymerase-2 inhibitors.
    Zhu Z; Jin J; Xue N; Song X; Chen X
    Anal Biochem; 2014 Mar; 449():188-94. PubMed ID: 24382396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The zebrafish: a powerful platform for in vivo, HTS drug discovery.
    Delvecchio C; Tiefenbach J; Krause HM
    Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput viability assay using an autonomously bioluminescent cell line with a bacterial Lux reporter.
    Class B; Thorne N; Aguisanda F; Southall N; McKew JC; Zheng W
    J Lab Autom; 2015 Apr; 20(2):164-74. PubMed ID: 25447977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction for interference by test samples in high-throughput assays.
    Shapiro AB; Walkup GK; Keating TA
    J Biomol Screen; 2009 Sep; 14(8):1008-16. PubMed ID: 19643982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AlphaLISA-based high-throughput screening assay to measure levels of soluble amyloid precursor protein α.
    Wang H; Nefzi A; Fields GB; Lakshmana MK; Minond D
    Anal Biochem; 2014 Aug; 459():24-30. PubMed ID: 24857774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel multi-layer microfluidic device towards characterization of drug metabolism and cytotoxicity for drug screening.
    Wu Q; Gao D; Wei J; Jin F; Xie W; Jiang Y; Liu H
    Chem Commun (Camb); 2014 Mar; 50(21):2762-4. PubMed ID: 24481240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformed insect cells as high throughput screening tools for the discovery of new bioactive compounds.
    Swevers L; Farrell PJ; Kravariti L; Xenou-Kokoletsi M; Sdralia N; Lioupis A; Morou E; Balatsos NA; Douris V; Georgoussi Z; Mazomenos B; Iatrou K
    Commun Agric Appl Biol Sci; 2003; 68(2 Pt B):333-41. PubMed ID: 24757768
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a high-throughput replicon assay for the identification of respiratory syncytial virus inhibitors.
    Tiong-Yip CL; Plant H; Sharpe P; Fan J; Rich K; Gorseth E; Yu Q
    Antiviral Res; 2014 Jan; 101():75-81. PubMed ID: 24246168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Versatile Cell Death Screening Assay Using Dye-Stained Cells and Multivariate Image Analysis.
    Collins TJ; Ylanko J; Geng F; Andrews DW
    Assay Drug Dev Technol; 2015 Nov; 13(9):547-57. PubMed ID: 26422066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Ligands by X-ray crystallography.
    Davies DR
    Methods Mol Biol; 2014; 1140():315-23. PubMed ID: 24590727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affordable luciferase reporter assay for cell-based high-throughput screening.
    Siebring-van Olst E; Vermeulen C; de Menezes RX; Howell M; Smit EF; van Beusechem VW
    J Biomol Screen; 2013 Apr; 18(4):453-61. PubMed ID: 23112084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cell aggregation and altered cell viability by automated label-free video microscopy: a promising alternative to endpoint viability assays in high-throughput screening.
    Aftab O; Fryknäs M; Hammerling U; Larsson R; Gustafsson MG
    J Biomol Screen; 2015 Mar; 20(3):372-81. PubMed ID: 25520371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.